NASDAQ: TOIIW Oncology Institute, Inc. 10-K

TOI posts 28% revenue growth but burns $24.6M cash; exits clinical trials, raises $30M equity

Filed March 12, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 26, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TOIIW commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.